← FDATracker
HomeAdverse Events

TYSABRI Adverse Event: Oligodendroglioma

TYSABRI Adverse Event: Oligodendroglioma is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: TYSABRI; Product category: Drug; Primary reaction: Oligodendroglioma.

Primary drugTYSABRI
Product categoryDrug
Primary reactionOligodendroglioma
All reactionsOligodendroglioma
SeriousnessSerious
Patient outcomeUnknown
Patient sexFemale
All drugs reportedTYSABRI; AUBAGIO; GILENYA
Reporter countryNO
Reporter type3
Report date20140313
Report ID10005509

🔍 Search all adverse events →